|
|
|
|
Two Distinguished Physicians Join ESUN's Medical Editorial Board
by Bruce Shriver, PhD Editor-in-Chief, ESUN
We are pleased to announce that two distinguished physicians have joined our Medical Editorial Advisory Board. We look forward to the contributions they will make to ESUN.
Junya Toguchida, MD, PhD Junya Toguchida, MD, PhD, is a Professor at the Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan. He is also a clinical professor of the Department of Orthopaedic Surgery, Kyoto University Hospital in Kyoto. Dr. Toguchida received a medical degree from Kyoto University. After completing the residency as an orthopedic surgeon and obtaining a doctorate of Medical Science from the Graduate School of Medicine, Kyoto University, he carried out a postdoctoral fellowship at the Massachusetts Eye & Ear Infirmary, Harvard University, Boston. In 1995, Dr. Toguchida became an associate professor in the Institute for Frontier Medicine, Kyoto University and also joined the staff in the Department of Orphopaedic Surgery, Kyoto University Hospital as a chief surgeon in the filed of Orthopedic Oncology. He was promoted to be a full professor of the Department of Tissue Regeneration in the Institute for Frontier Medicine since 2004.
Dr. Toguchida’s research interests center on clinical and biological research in the field of bone and soft tissue sarcomas, as well as tissue regeneration therapy for musculoskeletal disorders. He is currently performing a clinical application of mesenchymal stem cells for the treatment of extensive bone defects due to sarcomas. He is also managing the sarcoma tissue bank for the multi-institutional scientific study in Japan.
He is a contributor of more than 80 articles published in peer-reviewed journals such as Nature, New England Journal of Medicine, Cancer Research, Journal of National Cancer Institute, and Oncogene. He addresses a range of subjects that includes the role of tumor suppressor genes in sarcomas of bone and soft tissues, and the molecular profiling of sarcomas for the diagnosis and the development of molecular target therapy.
Dr. Toguchida is active in numerous professional organizations, most prominently Connective Tissue Oncology Society (CTOS), of which he was president in 2006. He is a board member of the Japanese Orthopedic Association, Japanese Clinical Cancer Association, Japanese Society of Tissue Engineering, and an active member of the American Association for Cancer Research (AACR), Societe Internationale de Chirurgie et de Traumatologie (SICOT), and Japanese Cancer Association.
Richard Gorlick, MD Dr. Gorlick is Associate Professor of Pediatrics and Molecular Pharmacology, Division Chief, Pediatric Hematology/Oncology, and Vice Chairman, Department of Pediatrics at Albert Einstein College of Medicine – The Children’s Hospital at Montefiore, in the Bronx, New York. He is also Director of the Sarcoma Research Laboratory and a member of the Albert Einstein Cancer Center at Albert Einstein College of Medicine. He earned his medical degree at State University of New York Health Science Center in Brooklyn, New York, and served his residency in Pediatrics at Babies Hospital of the Columbia-Presbyterian Medical Center, followed by a fellowship in Pediatric Hematology/Oncology at Memorial Sloan-Kettering Cancer Center in New York, New York.
Dr. Gorlick is an active member of the Children’s Oncology Group (COG) and has served as chairman of the Young Investigator Committee and currently serves as Vice Chairman of the Bone Sarcoma Disease Committee and chairman of the Biology Section–Bone Sarcoma Disease Committee and as a member of the Developmental Therapeutics Liaison committee. He is Co-chair of the Osteosarcoma Biology Protocol-Companion to Therapeutic Studies and Director of the Bone Tumor Resource Laboratory. Dr. Gorlick is an active member of the Pediatric Preclinical Testing Program (PPTP) and is responsible for the testing performed in osteosarcoma models. Dr. Gorlick is also an active member of the Sarcoma Alliance for Research through Collaboration (SARC) consortium preclinical testing group.
Dr. Gorlick has published more than 80 peer-reviewed articles in leading medical journals, including The New England Journal of Medicine, Cancer Research, Nature Medicine, Blood, and the Journal of Clinical Oncology. He is a frequent invited lecturer in bone tumors at major medical meetings throughout the United States and Europe.
Medical Editorial Advisory Board ESUN's board now consists of the following members:
V4N2 ESUN Copyright © 2007 Liddy Shriver Sarcoma Initiative. |
